Masimo Announces FDA Clearance of Neonatal Indication for O3® Regional Oximetry
Masimo (NASDAQ: MASI) announced today that O3® Regional Oximetry has received FDA clearance for use on neonatal indication and infant patients […]
Masimo (NASDAQ: MASI) announced today that O3® Regional Oximetry has received FDA clearance for use on neonatal indication and infant patients […]
Masimo (NASDAQ: MASI) announced today that Massena Memorial Hospital (MMH) of Massena, New York, has adopted Masimo Root® and Patient SafetyNet™*.
Masimo (NASDAQ: MASI) announced today the CE marking of noninvasive blood pressure (NIBP) measurements for the Rad-97™ Pulse CO-Oximeter® and connectivity